- Home
- LOGC vs NVRO Comparison
LOGC vs NVRO Comparison
Compare LOGC & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOGC
- NVRO
- Stock Information
- Founded
- LOGC 2010
- NVRO 2006
- Country
- LOGC United States
- NVRO United States
- Employees
- LOGC N/A
- NVRO N/A
- Industry
- LOGC Catalog/Specialty Distribution
- NVRO Medical/Dental Instruments
- Sector
- LOGC Consumer Discretionary
- NVRO Health Care
- Exchange
- LOGC Nasdaq
- NVRO Nasdaq
- Market Cap
- LOGC 186.8M
- NVRO 221.2M
- IPO Year
- LOGC 2020
- NVRO 2014
- Fundamental
- Price
- LOGC $6.47
- NVRO N/A
- Analyst Decision
- LOGC
- NVRO Hold
- Analyst Count
- LOGC 0
- NVRO 12
- Target Price
- LOGC N/A
- NVRO $7.24
- AVG Volume (30 Days)
- LOGC 325.3K
- NVRO 1.2M
- Earning Date
- LOGC 05-07-2025
- NVRO 05-06-2025
- Dividend Yield
- LOGC N/A
- NVRO N/A
- EPS Growth
- LOGC N/A
- NVRO N/A
- EPS
- LOGC N/A
- NVRO N/A
- Revenue
- LOGC $43,000,000.00
- NVRO $408,518,000.00
- Revenue This Year
- LOGC $433.37
- NVRO $1.54
- Revenue Next Year
- LOGC N/A
- NVRO $4.37
- P/E Ratio
- LOGC N/A
- NVRO N/A
- Revenue Growth
- LOGC N/A
- NVRO N/A
- 52 Week Low
- LOGC $4.69
- NVRO $3.17
- 52 Week High
- LOGC $9.34
- NVRO $13.84
- Technical
- Relative Strength Index (RSI)
- LOGC 33.31
- NVRO 3.08
- Support Level
- LOGC $6.76
- NVRO $5.83
- Resistance Level
- LOGC $7.40
- NVRO $5.86
- Average True Range (ATR)
- LOGC 0.30
- NVRO 0.02
- MACD
- LOGC -0.07
- NVRO -0.39
- Stochastic Oscillator
- LOGC 11.54
- NVRO 0.00
About LOGC ContextLogic Inc.
ContextLogic Inc is an online shopping store. The store provides personalized products, clothing products, accessories, gaming products and equipment, cosmetics, plastic products, mobile covers, and other products. Geographically, it derives majority of its revenue from Europe and also has a presence in North America; South America, and other countries.
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.